Free Trial
→ Trump Orders 'National Digital Asset Stockpile' (From Crypto 101 Media) (Ad) Buy CDNA Stock  Free CDNA Stock Alerts

CareDx (CDNA) Financials

CareDx logo
$15.00 -0.07 (-0.46%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$15.60 +0.61 (+4.03%)
As of 05/2/2025 05:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for CareDx

Annual Income Statements for CareDx

This table shows CareDx's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 0.78 -14 -39 -55 -47 -22 -19 -31 -77 -190 53
Consolidated Net Income / (Loss)		 0.78 -14 -40 -56 -47 -22 -19 -31 -77 -190 53
Net Income / (Loss) Continuing Operations		 0.78 -14 -40 -56 -47 -22 -19 -31 -77 -190 53
Total Pre-Tax Income 		-0.72 -14 -41 -57 -48 -24 -20 -32 -76 -190 53
Total Operating Income		 1.25 -12 -37 -20 -16 -25 -23 -30 -77 -203 41
Total Gross Profit		 19 18 20 27 44 82 129 199 210 178 224
Total Revenue		 27 28 41 48 77 127 192 296 322 280 334
Operating Revenue		 27 28 41 48 77 127 192 296 322 280 334
Total Cost of Revenue		 8.54 10 21 21 33 45 63 97 112 102 110
Operating Cost of Revenue		 8.54 10 21 21 33 45 63 97 112 102 110
Total Operating Expenses		 18 30 57 47 59 106 152 229 287 382 183
Selling, General & Admin Expense		 8.44 12 21 20 23 37 49 75 100 118 124
Marketing Expense		 6.47 8.35 11 13 22 39 54 77 96 83 82
Research & Development Expense		 3.85 9.33 12 12 15 31 49 77 90 82 72
Restructuring Charge		 - - - - - - - 0.00 0.00 2.32 1.78
Other Special Charges / (Income)		 -1.24 -0.13 -0.46 - - - - 0.00 0.00 96 -96
Total Other Income / (Expense), net		 -1.97 -1.78 -4.03 -37 -33 0.59 2.78 -2.36 1.00 13 12
Interest & Investment Income		 - -1.59 -1.86 -5.86 -3.70 0.99 0.27 0.16 3.76 12 12
Other Income / (Expense), net		 0.15 -0.19 -2.17 -31 -23 -0.40 2.51 -2.52 -2.77 1.35 0.33
Income Tax Expense		 -1.50 0.00 -1.61 -1.71 -1.43 -1.98 -1.04 -1.43 0.38 0.14 0.31
Basic Earnings per Share		 $0.13 ($1.16) ($2.39) ($2.38) ($1.31) ($0.52) ($0.40) ($0.59) ($1.44) ($3.54) $1.00
Weighted Average Basic Shares Outstanding		 5.82M 11.86M 16.50M 23.33M 35.64M 42.15M 46.48M 52.24M 53.32M 53.76M 52.77M
Diluted Earnings per Share		 $0.10 ($1.16) ($2.39) ($2.38) ($1.31) ($0.52) ($0.40) ($0.59) ($1.44) ($3.54) $0.93
Weighted Average Diluted Shares Outstanding		 9.28M 11.86M 16.50M 23.33M 35.64M 42.15M 46.48M 52.24M 53.32M 53.76M 56.62M
Weighted Average Basic & Diluted Shares Outstanding		 6M 11.80M 16.50M 23.30M 35.70M 42.88M 51.82M 53.03M 53.67M 51.78M 55.43M

Quarterly Income Statements for CareDx

This table shows CareDx's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -17 -18 -24 -25 -23 -118 -17 -1.39 -7.41 78 -10
Consolidated Net Income / (Loss)		 -17 -18 -24 -25 -23 -118 -17 -1.39 -7.41 78 -10
Net Income / (Loss) Continuing Operations		 -17 -18 -24 -25 -23 -118 -17 -1.39 -7.41 78 -10
Total Pre-Tax Income 		-17 -18 -24 -25 -24 -118 -17 -1.37 -7.21 78 -10
Total Operating Income		 -17 -19 -24 -28 -29 -123 -19 -4.10 -10 75 -13
Total Gross Profit		 51 53 51 44 43 40 46 64 55 58 56
Total Revenue		 79 82 77 70 67 66 72 92 83 87 85
Operating Revenue		 79 82 77 70 67 66 72 92 83 87 85
Total Cost of Revenue		 28 29 26 26 25 26 26 28 28 28 28
Operating Cost of Revenue		 28 29 26 26 25 26 26 28 28 28 28
Total Operating Expenses		 68 72 76 72 71 163 65 68 66 -16 70
Selling, General & Admin Expense		 24 25 28 29 34 27 27 28 29 41 23
Marketing Expense		 22 24 23 22 18 20 20 21 20 21 23
Research & Development Expense		 22 24 24 20 19 18 19 20 17 17 19
Other Special Charges / (Income)		 - - - - - - - - - - 5.36
Total Other Income / (Expense), net		 0.67 0.96 0.70 2.60 5.22 4.70 2.60 2.73 3.28 3.49 3.08
Interest & Investment Income		 1.23 1.87 2.67 2.87 3.17 3.16 2.89 2.83 3.00 3.05 2.78
Other Income / (Expense), net		 -0.56 -0.91 -1.97 -0.27 2.05 1.54 -0.29 -0.10 0.28 0.44 0.30
Income Tax Expense		 0.27 0.17 0.12 -0.07 -0.08 0.17 -0.08 0.02 0.20 0.17 0.06
Basic Earnings per Share		 ($0.32) ($0.34) ($0.44) ($0.46) ($0.43) ($2.21) ($0.32) ($0.03) ($0.14) $1.49 ($0.19)
Weighted Average Basic Shares Outstanding		 53.49M 53.32M 53.64M 53.85M 54.18M 53.76M 51.69M 52.20M 52.90M 52.77M 55.26M
Diluted Earnings per Share		 ($0.32) ($0.34) ($0.44) ($0.46) ($0.43) ($2.21) ($0.32) ($0.03) ($0.14) $1.42 ($0.19)
Weighted Average Diluted Shares Outstanding		 53.49M 53.32M 53.64M 53.85M 54.18M 53.76M 51.69M 52.20M 52.90M 56.62M 55.26M
Weighted Average Basic & Diluted Shares Outstanding		 53.54M 53.67M 53.79M 54.17M 54.10M 51.78M 52.08M 52.74M 53.63M 55.43M 55.68M

Annual Cash Flow Statements for CareDx

This table details how cash moves in and out of CareDx's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 31 -6.54 -13 8.97 38 -25 96 214 -258 -7.66 32
Net Cash From Operating Activities		 -3.35 -9.75 -17 -14 -4.01 -2.77 33 -19 -25 -18 38
Net Cash From Continuing Operating Activities		 -3.35 -9.75 -17 -14 -4.01 -2.77 33 -19 -25 -18 38
Net Income / (Loss) Continuing Operations		 0.78 -14 -40 -56 -47 -22 -19 -31 -77 -190 53
Consolidated Net Income / (Loss)		 0.78 -14 -40 -56 -47 -22 -19 -31 -77 -190 53
Depreciation Expense		 0.51 0.80 2.92 3.73 4.22 5.52 7.01 8.80 12 14 14
Amortization Expense		 0.07 0.12 4.03 3.87 2.47 1.62 2.54 4.22 4.80 0.51 6.18
Non-Cash Adjustments To Reconcile Net Income		 -1.19 1.34 15 34 36 22 25 40 48 48 66
Changes in Operating Assets and Liabilities, net		 -3.53 1.70 1.02 0.05 0.15 -10 18 -42 -13 109 -101
Net Cash From Investing Activities		 -1.33 -1.20 -21 -6.11 -7.93 -23 -100 48 -229 40 -0.48
Net Cash From Continuing Investing Activities		 -1.33 -1.20 -21 -6.11 -7.93 -23 -100 48 -229 40 -0.48
Purchase of Property, Plant & Equipment		 -0.73 -1.20 -0.55 -0.19 -2.04 -2.20 -7.11 -14 -21 -8.34 -6.48
Acquisitions		 -0.60 - 0.00 -5.92 -5.89 -20 -3.25 -22 -3.71 -7.58 0.00
Purchase of Investments		 - - - - 0.00 0.00 -90 -5.50 -315 -202 -161
Sale and/or Maturity of Investments		 - - - - - 0.00 0.00 89 112 258 167
Net Cash From Financing Activities		 36 4.41 25 29 50 -0.13 163 186 -4.54 -30 -5.61
Net Cash From Continuing Financing Activities		 36 4.41 25 29 50 -0.13 163 186 -4.54 -30 -5.61
Repurchase of Common Equity		 -3.73 - - - - - 0.00 0.00 -0.64 -28 -0.52
Issuance of Common Equity		 39 0.20 8.23 18 53 0.76 160 191 2.23 1.50 1.40
Other Financing Activities, net		 0.02 0.05 0.02 1.25 12 -0.72 3.83 -5.29 -6.12 -3.56 -6.48
Effect of Exchange Rate Changes		 0.00 0.00 - - 0.00 - 0.27 -0.30 0.02 -0.11 0.53
Cash Interest Paid		 1.21 1.36 0.87 3.27 1.77 0.02 0.01 0.00 0.01 0.00 0.00
Cash Income Taxes Paid		 - - - - 0.00 0.00 0.08 0.01 0.39 0.74 0.32

Quarterly Cash Flow Statements for CareDx

This table details how cash moves in and out of CareDx's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents		 -84 7.29 -15 13 -12 6.22 11 2.49 -0.38 19 -26
Net Cash From Operating Activities		 -7.08 7.19 0.67 -0.50 -10 -8.38 -15 19 13 22 -27
Net Cash From Continuing Operating Activities		 -7.08 7.19 0.67 -0.50 -10 -8.38 -15 19 13 22 -27
Net Income / (Loss) Continuing Operations		 -17 -18 -24 -25 -23 -118 -17 -1.39 -7.41 78 -10
Consolidated Net Income / (Loss)		 -17 -18 -24 -25 -23 -118 -17 -1.39 -7.41 78 -10
Depreciation Expense		 3.03 3.21 3.43 3.67 3.66 3.63 3.82 3.54 3.47 3.36 3.60
Amortization Expense		 1.75 0.69 0.56 -0.00 0.05 -0.10 2.85 0.78 1.78 0.77 2.18
Non-Cash Adjustments To Reconcile Net Income		 12 13 16 13 11 8.50 13 13 14 26 8.92
Changes in Operating Assets and Liabilities, net		 -6.67 8.55 4.78 8.15 -1.34 98 -19 2.85 0.99 -87 -31
Net Cash From Investing Activities		 -76 2.48 -15 15 -1.50 41 28 -12 -14 -2.11 1.33
Net Cash From Continuing Investing Activities		 -76 2.48 -15 15 -1.50 41 28 -12 -14 -2.11 1.33
Purchase of Property, Plant & Equipment		 -4.85 -3.28 -2.77 -2.36 -1.62 -1.59 -1.49 -1.79 -1.69 -1.52 -1.63
Purchase of Investments		 -101 -32 -86 -49 -58 -9.03 -58 -35 -50 -18 -52
Sale and/or Maturity of Investments		 31 37 79 67 61 52 87 26 37 17 55
Net Cash From Financing Activities		 -1.03 -2.37 -1.14 -1.57 -0.03 -27 -1.28 -4.85 1.42 -0.90 -0.64
Net Cash From Continuing Financing Activities		 -1.03 -2.37 -1.14 -1.57 -0.03 -27 -1.28 -4.85 1.42 -0.90 -0.64
Repurchase of Common Equity		 - -0.64 -0.69 -0.07 -0.81 -26 -0.52 - - - 0.00
Issuance of Common Equity		 1.23 -0.00 0.46 - 1.04 - 0.53 - 0.87 - 0.87
Other Financing Activities, net		 -2.26 -1.73 -0.90 -1.50 -0.25 -0.91 -1.29 -4.85 0.56 -0.90 -1.52
Effect of Exchange Rate Changes		 -0.03 -0.00 -0.03 -0.09 -0.11 0.11 0.03 0.02 0.08 0.41 -0.08

Annual Balance Sheets for CareDx

This table presents CareDx's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 61 56 77 84 131 152 369 567 543 467 491
Total Current Assets		 40 34 27 27 81 72 273 433 388 314 352
Cash & Equivalents		 36 30 17 17 65 38 135 348 90 82 115
Short-Term Investments		 - - - - - 0.00 90 0.00 203 153 146
Accounts Receivable		 2.69 2.37 2.77 2.99 9.76 24 35 60 66 51 65
Inventories, net		 0.69 0.77 5.46 5.53 4.94 6.01 10 17 19 19 20
Prepaid Expenses		 0.54 1.34 1.19 1.35 1.80 3.63 3.76 7.93 9.22 7.76 7.07
Plant, Property, & Equipment, net		 1.97 2.43 2.93 2.08 0.00 0.00 0.00 0.00 0.00 35 34
Total Noncurrent Assets		 19 19 47 55 50 80 95 133 155 118 106
Goodwill		 12 12 14 12 12 24 24 37 38 40 40
Intangible Assets		 6.65 6.65 33 33 33 46 44 50 43 46 38
Other Noncurrent Operating Assets		 0.17 0.20 0.02 - 4.13 10 27 46 74 31 27
Other Noncurrent Nonoperating Assets		 - - 0.14 9.58 0.19 0.26 0.27 0.21 0.52 0.59 0.59
Total Liabilities & Shareholders' Equity		 61 56 77 84 131 152 369 567 543 467 491
Total Liabilities		 20 26 57 90 35 53 91 101 112 205 113
Total Current Liabilities		 11 10 41 43 20 35 69 77 76 78 89
Accounts Payable		 1.13 1.64 3.07 3.39 4.71 5.51 9.65 13 9.94 13 7.69
Accrued Expenses		 1.86 3.13 5.58 3.74 5.64 17 21 38 49 45 43
Current Employee Benefit Liabilities		 1.68 2.37 3.85 5.01 9.16 12 18 26 17 20 38
Total Noncurrent Liabilities		 8.71 16 16 47 15 18 22 23 36 127 23
Noncurrent Deferred & Payable Income Tax Liabilities		 - 0.00 6.06 4.93 2.97 1.97 1.30 0.42 0.00 0.14 0.16
Other Noncurrent Operating Liabilities		 1.10 0.98 6.92 22 12 16 20 23 36 127 23
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 41 29 20 -5.95 96 99 278 466 431 261 378
Total Preferred & Common Equity		 41 29 19 -6.13 96 99 278 466 431 261 378
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 41 29 19 -6.13 96 99 278 466 431 261 378
Common Stock		 201 203 236 264 412 438 632 854 899 947 1,013
Retained Earnings		 -159 -173 -213 -268 -312 -334 -353 -383 -460 -678 -626
Accumulated Other Comprehensive Income / (Loss)		 - 0.00 -3.66 -2.35 -4.28 -5.21 -2.10 -4.67 -7.50 -6.96 -8.57

Quarterly Balance Sheets for CareDx

This table presents CareDx's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Total Assets		 545 528 515 501 452 467 477 490
Total Current Assets		 388 371 361 345 303 321 334 350
Cash & Equivalents		 83 75 88 76 93 96 95 89
Short-Term Investments		 208 211 195 192 123 133 145 142
Accounts Receivable		 70 59 52 52 60 66 67 71
Inventories, net		 18 18 19 18 20 19 19 23
Prepaid Expenses		 8.37 8.16 7.68 7.31 6.90 6.34 7.34 25
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 34 34 34 33
Total Noncurrent Assets		 156 157 154 156 115 112 109 107
Goodwill		 38 40 40 40 40 40 40 40
Intangible Assets		 44 46 44 46 43 42 40 37
Other Noncurrent Operating Assets		 75 71 70 69 31 29 28 29
Other Noncurrent Nonoperating Assets		 0.20 0.52 0.58 0.58 0.58 0.59 0.59 0.55
Total Liabilities & Shareholders' Equity		 545 528 515 501 452 467 477 490
Total Liabilities		 108 108 110 107 196 202 204 110
Total Current Liabilities		 70 72 74 73 70 78 81 85
Accounts Payable		 11 13 9.88 8.97 9.98 5.87 6.24 8.07
Accrued Expenses		 45 47 50 47 46 47 45 43
Current Employee Benefit Liabilities		 14 12 14 17 15 25 30 14
Other Current Liabilities		 - - - - - - - 20
Total Noncurrent Liabilities		 38 36 35 34 125 122 121 25
Noncurrent Deferred & Payable Income Tax Liabilities		 0.01 - 0.05 0.14 0.04 0.05 0.20 0.13
Other Noncurrent Operating Liabilities		 38 36 35 34 125 122 121 25
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 437 420 405 394 256 265 273 379
Total Preferred & Common Equity		 437 420 405 394 256 265 273 379
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 437 420 405 394 256 265 273 379
Common Stock		 887 912 924 937 960 969 985 1,023
Retained Earnings		 -441 -485 -510 -534 -695 -697 -704 -637
Accumulated Other Comprehensive Income / (Loss)		 -8.81 -7.44 -8.45 -8.67 -8.11 -7.96 -7.18 -7.09

Annual Metrics and Ratios for CareDx

This table displays calculated financial ratios and metrics derived from CareDx's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 23.57% 3.07% 44.37% 18.93% 58.45% 65.95% 51.25% 54.22% 8.57% -12.89% 19.07%
EBITDA Growth		 635.41% -665.72% -190.47% -33.17% 26.06% 44.50% 41.10% -83.58% -230.66% -194.21% 132.85%
EBIT Growth		 200.29% -967.57% -225.92% -28.97% 23.97% 35.63% 19.70% -61.07% -148.07% -152.53% 120.34%
NOPAT Growth		 245.86% -1,054.56% -212.87% 45.64% 23.24% -57.48% 8.17% -31.95% -159.81% -163.32% 128.47%
Net Income Growth		 122.05% -1,855.06% -190.04% -39.75% 15.80% 53.04% 14.81% -63.85% -149.86% -148.37% 127.62%
EPS Growth		 102.86% -1,260.00% -106.03% 0.42% 44.96% 60.31% 23.08% -47.50% -144.07% -145.83% 126.27%
Operating Cash Flow Growth		 -513.55% -191.10% -69.43% 13.41% 71.99% 30.90% 1,307.33% -157.71% -30.81% 27.14% 306.92%
Free Cash Flow Firm Growth		 -546.10% 63.97% -398.86% 128.23% -485.91% -15.30% 82.92% -972.11% 13.02% 59.05% -69.02%
Invested Capital Growth		 411.62% -5.65% 71.26% -93.80% 1,808.03% 94.48% -12.91% 122.33% 17.17% -81.56% 362.78%
Revenue Q/Q Growth		 0.00% -4.43% 11.56% 3.52% 16.79% 10.73% 6.22% 12.16% 0.99% -5.66% 6.72%
EBITDA Q/Q Growth		 0.00% -62.11% -86.67% -49.56% 47.39% -23.60% 32.43% -399.84% -4.37% -118.37% 145.42%
EBIT Q/Q Growth		 0.00% -72.13% -72.26% -39.46% 43.15% -21.08% 18.71% -103.30% -3.84% -100.12% 126.49%
NOPAT Q/Q Growth		 0.00% -69.46% -62.79% 41.80% 10.73% -14.62% 67.69% -208.83% -5.06% -103.67% 136.98%
Net Income Q/Q Growth		 0.00% -53.13% -38.02% -40.15% 37.34% -4.85% 6.29% -70.10% -2.93% -110.22% 136.60%
EPS Q/Q Growth		 0.00% -397.44% -6.22% -46.01% 48.43% -8.33% 13.04% -78.79% -2.13% -111.98% 134.44%
Operating Cash Flow Q/Q Growth		 5.53% -50.08% 5.25% 5.99% 50.86% -987.50% 32.84% -18.52% 10.68% -551.59% 389.17%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 10.22% 364.04% -74.68% -16.53% 83.08% -144.01% 15.71% 39.32% -196.21%
Invested Capital Q/Q Growth		 0.00% -1.97% -35.71% -92.03% -0.82% 7.37% -3.44% 7.84% -5.44% -79.80% 253.95%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 68.72% 63.50% 48.02% 55.78% 56.92% 64.23% 67.16% 67.14% 65.13% 63.61% 67.16%
EBITDA Margin		 7.25% -39.82% -80.12% -89.71% -41.86% -14.00% -5.45% -6.49% -19.76% -66.75% 18.42%
Operating Margin		 4.58% -42.40% -91.88% -42.00% -20.35% -19.31% -11.72% -10.03% -24.00% -72.55% 12.21%
EBIT Margin		 5.12% -43.06% -97.22% -105.43% -50.59% -19.62% -10.42% -10.88% -24.86% -72.06% 12.31%
Profit (Net Income) Margin		 2.86% -48.70% -97.85% -114.97% -61.10% -17.29% -9.74% -10.34% -23.81% -67.88% 15.74%
Tax Burden Percent		 -108.62% 100.00% 96.12% 97.02% 97.03% 91.74% 94.75% 95.56% 100.50% 100.07% 99.41%
Interest Burden Percent		 -51.47% 113.09% 104.71% 112.41% 124.48% 96.05% 98.65% 99.50% 95.30% 94.13% 128.63%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.59%
Return on Invested Capital (ROIC)		 15.83% -52.80% -125.45% -101.71% -66.59% -37.48% -27.85% -24.50% -42.49% -175.07% 56.87%
ROIC Less NNEP Spread (ROIC-NNEP)		 17.10% -25.45% 233.45% -687.13% 58.80% -28.19% -25.62% -21.06% -35.47% -156.97% 52.04%
Return on Net Nonoperating Assets (RNNOA)		 -9.78% 14.08% -35.98% -703.10% -37.40% 14.94% 17.92% 16.25% 25.40% 120.10% -40.44%
Return on Equity (ROE)		 6.05% -38.72% -161.43% -804.81% -103.99% -22.54% -9.94% -8.25% -17.09% -54.98% 16.43%
Cash Return on Invested Capital (CROIC)		 -126.72% -46.98% -177.99% 74.94% -246.67% -101.64% -14.05% -100.40% -58.30% -37.36% -72.05%
Operating Return on Assets (OROA)		 3.93% -20.76% -59.69% -63.57% -36.16% -17.66% -7.70% -6.90% -14.42% -40.01% 8.58%
Return on Assets (ROA)		 2.20% -23.48% -60.07% -69.32% -43.67% -15.56% -7.19% -6.56% -13.81% -37.69% 10.97%
Return on Common Equity (ROCE)		 -25.61% -38.72% -160.51% -778.05% -103.78% -22.54% -9.94% -8.25% -17.09% -54.98% 16.43%
Return on Equity Simple (ROE_SIMPLE)		 1.89% -46.47% -204.07% 905.77% -48.77% -22.19% -6.74% -6.58% -17.78% -72.81% 13.89%
Net Operating Profit after Tax (NOPAT)		 0.88 -8.35 -26 -14 -11 -17 -16 -21 -54 -142 41
NOPAT Margin		 3.20% -29.68% -64.32% -29.40% -14.24% -13.51% -8.21% -7.02% -16.80% -50.78% 12.14%
Net Nonoperating Expense Percent (NNEP)		 -1.27% -27.35% -358.89% 585.42% -125.39% -9.29% -2.24% -3.44% -7.02% -18.10% 4.84%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -12.55% -54.47% 10.71%
Cost of Revenue to Revenue		 31.28% 36.50% 51.98% 44.22% 43.08% 35.77% 32.84% 32.86% 34.87% 36.39% 32.84%
SG&A Expenses to Revenue		 30.89% 43.52% 51.01% 41.58% 30.01% 28.76% 25.39% 25.29% 31.20% 42.05% 37.08%
R&D to Revenue		 14.08% 33.16% 30.48% 25.64% 18.96% 24.17% 25.46% 25.82% 28.09% 29.20% 21.69%
Operating Expenses to Revenue		 64.14% 105.89% 139.90% 97.77% 77.26% 83.53% 78.88% 77.17% 89.13% 136.16% 54.94%
Earnings before Interest and Taxes (EBIT)		 1.40 -12 -40 -51 -39 -25 -20 -32 -80 -202 41
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1.98 -11 -33 -43 -32 -18 -10 -19 -64 -187 61
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.07 2.58 2.95 0.00 10.20 9.25 12.85 5.15 1.42 2.48 3.03
Price to Tangible Book Value (P/TBV)		 3.78 7.03 0.00 0.00 19.30 30.92 17.04 6.34 1.74 3.70 3.83
Price to Revenue (P/Rev)		 3.13 2.71 1.41 4.34 12.77 7.20 18.57 8.10 1.90 2.32 3.44
Price to Earnings (P/E)		 109.57 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 21.85
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.91% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 4.58%
Enterprise Value to Invested Capital (EV/IC)		 3.72 4.04 2.45 139.32 29.35 14.49 63.45 17.52 2.31 16.34 7.57
Enterprise Value to Revenue (EV/Rev)		 2.22 2.20 1.59 4.70 11.93 6.90 17.40 6.93 0.99 1.48 2.66
Enterprise Value to EBITDA (EV/EBITDA)		 30.57 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 14.44
Enterprise Value to EBIT (EV/EBIT)		 43.35 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 21.60
Enterprise Value to NOPAT (EV/NOPAT)		 69.21 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 21.90
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 100.03 0.00 0.00 0.00 23.33
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 21.71 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.28 0.53 1.21 -5.72 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.13 0.44 0.06 -3.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.57 -0.55 -0.15 1.02 -0.64 -0.53 -0.70 -0.77 -0.72 -0.77 -0.78
Leverage Ratio		 2.75 1.65 2.69 11.61 2.38 1.45 1.38 1.26 1.24 1.46 1.50
Compound Leverage Factor		 -1.42 1.87 2.81 13.05 2.96 1.39 1.36 1.25 1.18 1.37 1.93
Debt to Total Capital		 21.65% 34.82% 54.79% 121.18% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 11.31% 6.33% 52.27% 55.94% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 10.34% 28.48% 2.51% 65.25% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.64% 0.64% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 78.35% 65.18% 44.58% -21.83% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 5.76 -1.41 -0.74 -0.79 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 -12.63 1.26 -0.21 -0.40 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 2.75 -1.15 -0.03 -0.42 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 13.04 -1.89 -0.92 -2.40 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 -28.59 1.69 -0.26 -1.21 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 6.23 -1.54 -0.04 -1.29 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 0.03 -2.30 -4.66 -4.75 13.71 7.92 23.24 14.44 2.88 -0.36 5.93
Noncontrolling Interest Sharing Ratio		 523.49% 0.00% 0.57% 3.32% 0.20% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.62 3.38 0.65 0.62 4.16 2.07 3.95 5.61 5.11 4.02 3.94
Quick Ratio		 3.51 3.18 0.49 0.46 3.81 1.79 3.75 5.28 4.73 3.67 3.64
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -21 -7.43 -37 10 -40 -47 -7.95 -85 -74 -30 -51
Operating Cash Flow to CapEx		 -457.03% -813.34% -3,009.65% -7,691.94% -196.90% -125.81% 470.20% -142.30% -118.86% -220.37% 586.80%
Free Cash Flow to Firm to Interest Expense		 -9.75 0.00 0.00 22.80 -6.99 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 -1.58 0.00 0.00 -31.17 -0.69 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -1.93 0.00 0.00 -31.58 -1.05 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.77 0.48 0.61 0.60 0.71 0.90 0.74 0.63 0.58 0.56 0.70
Accounts Receivable Turnover		 11.02 11.14 15.83 16.78 12.01 7.52 6.55 6.28 5.10 4.78 5.77
Inventory Turnover		 14.19 14.15 6.78 3.89 6.30 8.30 7.88 7.16 6.16 5.27 5.63
Fixed Asset Turnover		 15.51 12.81 15.17 19.31 0.00 0.00 0.00 0.00 0.00 0.00 9.70
Accounts Payable Turnover		 9.78 7.41 8.97 6.62 8.14 8.90 8.33 8.47 9.64 8.94 10.67
Days Sales Outstanding (DSO)		 33.13 32.77 23.06 21.75 30.39 48.57 55.72 58.12 71.50 76.41 63.24
Days Inventory Outstanding (DIO)		 25.73 25.79 53.80 93.85 57.94 43.99 46.34 50.97 59.23 69.25 64.88
Days Payable Outstanding (DPO)		 37.31 49.24 40.69 55.13 44.82 41.02 43.83 43.08 37.86 40.82 34.22
Cash Conversion Cycle (CCC)		 21.55 9.32 36.18 60.47 43.50 51.54 58.23 66.00 92.87 104.84 93.90
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 16 15 26 1.63 31 61 53 117 137 25 117
Invested Capital Turnover		 4.94 1.78 1.95 3.46 4.68 2.77 3.39 3.49 2.53 3.45 4.68
Increase / (Decrease) in Invested Capital		 22 -0.92 11 -25 29 29 -7.82 64 20 -112 92
Enterprise Value (EV)		 61 62 64 227 913 877 3,344 2,053 318 414 888
Market Capitalization		 86 76 57 210 978 915 3,569 2,401 611 649 1,148
Book Value per Share		 $3.50 $2.48 $0.92 ($0.21) $2.47 $2.33 $5.64 $8.82 $8.05 $4.83 $7.06
Tangible Book Value per Share		 $1.92 $0.91 ($1.29) ($1.79) $1.30 $0.70 $4.25 $7.17 $6.54 $3.24 $5.59
Total Capital		 53 45 44 28 96 99 278 466 431 261 378
Total Debt		 11 16 24 34 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 5.45 13 1.10 18 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -25 -14 6.69 17 -65 -38 -225 -348 -293 -235 -261
Capital Expenditures (CapEx)		 0.73 1.20 0.55 0.19 2.04 2.20 7.11 14 21 8.34 6.48
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -1.26 -2.81 -8.57 -17 -3.01 -1.13 -21 7.57 19 0.22 1.81
Debt-free Net Working Capital (DFNWC)		 35 27 8.69 -0.42 62 37 204 356 312 236 262
Net Working Capital (NWC)		 29 24 -14 -16 62 37 204 356 312 236 262
Net Nonoperating Expense (NNE)		 0.09 5.35 14 41 36 4.80 2.94 9.85 23 48 -12
Net Nonoperating Obligations (NNO)		 -25 -14 6.54 7.59 -65 -38 -225 -349 -294 -236 -261
Total Depreciation and Amortization (D&A)		 0.58 0.91 6.95 7.60 6.68 7.14 9.54 13 16 15 20
Debt-free, Cash-free Net Working Capital to Revenue		 -4.61% -9.99% -21.09% -35.83% -3.93% -0.89% -10.83% 2.56% 5.84% 0.08% 0.54%
Debt-free Net Working Capital to Revenue		 128.81% 96.21% 21.38% -0.87% 80.46% 29.19% 106.08% 120.13% 96.92% 84.06% 78.63%
Net Working Capital to Revenue		 106.98% 86.02% -34.85% -33.40% 80.46% 29.19% 106.08% 120.13% 96.92% 84.06% 78.63%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.13 ($1.16) ($2.39) ($2.38) ($1.31) ($0.52) ($0.40) ($0.59) ($1.44) ($3.54) $1.00
Adjusted Weighted Average Basic Shares Outstanding		 5.82M 11.86M 16.50M 23.33M 35.64M 42.15M 46.48M 52.24M 53.32M 53.76M 52.77M
Adjusted Diluted Earnings per Share		 $0.10 ($1.16) ($2.39) ($2.38) ($1.31) ($0.52) ($0.40) ($0.59) ($1.44) ($3.54) $0.93
Adjusted Weighted Average Diluted Shares Outstanding		 9.28M 11.86M 16.50M 23.33M 35.64M 42.15M 46.48M 52.24M 53.32M 53.76M 56.62M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 11.81M 11.97M 16.50M 29.07M 41.73M 42.88M 51.82M 53.03M 53.67M 51.78M 55.43M
Normalized Net Operating Profit after Tax (NOPAT)		 0.01 -8.44 -17 -13 -11 -17 -16 -21 -54 -73 -53
Normalized NOPAT Margin		 0.03% -29.99% -42.67% -26.56% -14.24% -13.51% -8.21% -7.02% -16.80% -26.16% -16.01%
Pre Tax Income Margin		 -2.63% -48.70% -101.80% -118.51% -62.97% -18.85% -10.28% -10.83% -23.69% -67.83% 15.84%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.66 0.00 0.00 -111.00 -6.70 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.41 0.00 0.00 -30.95 -1.89 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.31 0.00 0.00 -111.40 -7.05 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.07 0.00 0.00 -31.35 -2.24 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 477.98% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -0.84% -14.47% 0.99%

Quarterly Metrics and Ratios for CareDx

This table displays calculated financial ratios and metrics derived from CareDx's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 4.99% 3.99% -2.71% -12.81% -15.33% -20.41% -6.75% 31.26% 23.35% 32.04% 17.54%
EBITDA Growth		 -49.67% -19.76% -36.68% -34.36% -75.50% -628.78% 41.91% 100.53% 78.44% 167.42% 54.88%
EBIT Growth		 -48.17% -17.35% -32.46% -25.50% -49.39% -504.67% 25.35% 84.95% 61.82% 162.04% 42.78%
NOPAT Growth		 -98.68% -24.16% -27.66% -27.19% -66.00% -541.38% 20.50% 85.17% 63.55% 186.82% 40.73%
Net Income Growth		 -42.38% -13.49% -20.87% -15.01% -38.64% -544.32% 29.85% 94.41% 68.46% 166.06% 47.94%
EPS Growth		 -39.13% -9.68% -18.92% -12.20% -34.38% -550.00% 27.27% 93.48% 67.44% 164.25% 50.00%
Operating Cash Flow Growth		 -1,953.14% 72.47% 103.13% 87.13% -43.79% -216.65% -2,381.97% 3,897.39% 223.02% 361.17% -73.62%
Free Cash Flow Firm Growth		 19.10% 55.48% 77.08% 90.24% 99.36% 178.00% 732.63% 2,073.64% 27,394.31% -166.36% -251.47%
Invested Capital Growth		 33.64% 17.17% -3.29% -11.06% -13.66% -81.56% -69.25% -69.80% -73.59% 362.78% 260.08%
Revenue Q/Q Growth		 -1.58% 3.81% -6.22% -9.01% -4.42% -2.42% 9.88% 28.07% -10.18% 4.46% -2.19%
EBITDA Q/Q Growth		 27.24% -22.95% -38.24% -8.65% 4.97% -410.57% 88.98% 101.00% -3,948.06% 1,696.70% -109.21%
EBIT Q/Q Growth		 19.47% -11.90% -31.28% -6.09% 4.14% -352.91% 83.79% 78.61% -143.19% 835.90% -117.41%
NOPAT Q/Q Growth		 20.17% -10.27% -27.22% -13.57% -4.20% -326.06% 84.23% 78.81% -156.03% 1,114.77% -112.56%
Net Income Q/Q Growth		 21.93% -8.21% -29.57% -5.07% 5.88% -402.86% 85.89% 91.63% -431.42% 1,153.05% -113.27%
EPS Q/Q Growth		 21.95% -6.25% -29.41% -4.55% 6.52% -413.95% 85.52% 90.63% -366.67% 1,114.29% -113.38%
Operating Cash Flow Q/Q Growth		 -82.59% 201.50% -90.66% -174.37% -1,939.88% 17.66% -82.70% 223.75% -33.92% 74.80% -221.45%
Free Cash Flow Firm Q/Q Growth		 -14.03% 31.18% 62.75% 66.61% 92.54% 8,500.39% 202.13% 4.18% 3.23% -120.42% -569.89%
Invested Capital Q/Q Growth		 5.89% -5.44% -2.72% -8.69% 2.80% -79.80% 62.17% -10.32% -10.10% 253.95% 26.18%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 64.34% 64.20% 66.39% 63.18% 63.49% 60.94% 64.01% 69.71% 66.73% 67.45% 66.45%
EBITDA Margin		 -16.53% -19.58% -28.86% -34.46% -34.27% -179.29% -17.98% 0.14% -5.99% 91.55% -8.62%
Operating Margin		 -21.85% -23.21% -31.48% -39.29% -42.84% -187.03% -26.84% -4.44% -12.66% 86.27% -15.79%
EBIT Margin		 -22.55% -24.31% -34.03% -39.68% -39.79% -184.68% -27.24% -4.55% -12.32% 86.77% -15.44%
Profit (Net Income) Margin		 -21.34% -22.25% -30.74% -35.49% -34.95% -180.11% -23.12% -1.51% -8.94% 90.10% -12.23%
Tax Burden Percent		 101.60% 100.95% 100.52% 99.73% 99.66% 100.14% 99.50% 101.60% 102.77% 99.78% 100.56%
Interest Burden Percent		 93.16% 90.66% 89.86% 89.71% 88.14% 97.39% 85.30% 32.68% 70.60% 104.06% 78.71%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.22% 0.00%
Return on Invested Capital (ROIC)		 -38.39% -41.09% -51.86% -65.68% -65.86% -451.35% -59.19% -11.63% -34.98% 403.21% -40.54%
ROIC Less NNEP Spread (ROIC-NNEP)		 -36.93% -39.55% -49.64% -63.77% -64.67% -439.16% -57.95% -12.21% -34.95% 401.81% -40.09%
Return on Net Nonoperating Assets (RNNOA)		 26.61% 28.32% 34.27% 44.31% 43.61% 335.99% 42.98% 9.32% 26.65% -312.30% 28.17%
Return on Equity (ROE)		 -11.78% -12.76% -17.59% -21.37% -22.25% -115.35% -16.21% -2.32% -8.32% 90.91% -12.36%
Cash Return on Invested Capital (CROIC)		 -69.33% -58.30% -39.17% -36.06% -37.00% -37.36% -53.11% -46.94% -21.88% -72.05% -60.56%
Operating Return on Assets (OROA)		 -12.97% -14.10% -20.24% -23.24% -22.61% -102.53% -15.28% -2.75% -7.88% 60.48% -11.36%
Return on Assets (ROA)		 -12.28% -12.90% -18.28% -20.79% -19.86% -100.00% -12.97% -0.91% -5.72% 62.80% -8.99%
Return on Common Equity (ROCE)		 -11.78% -12.76% -17.59% -21.37% -22.25% -115.35% -16.21% -2.32% -8.32% 90.91% -12.36%
Return on Equity Simple (ROE_SIMPLE)		 -17.05% 0.00% -19.22% -20.72% -22.97% 0.00% -71.50% -60.32% -52.54% 0.00% 16.37%
Net Operating Profit after Tax (NOPAT)		 -12 -13 -17 -19 -20 -86 -14 -2.87 -7.34 75 -9.36
NOPAT Margin		 -15.29% -16.25% -22.04% -27.51% -29.99% -130.92% -18.79% -3.11% -8.86% 86.08% -11.05%
Net Nonoperating Expense Percent (NNEP)		 -1.47% -1.54% -2.22% -1.90% -1.19% -12.18% -1.25% 0.58% -0.03% 1.40% -0.44%
Return On Investment Capital (ROIC_SIMPLE)		 - -3.11% - - - -32.85% - - - 19.69% -2.47%
Cost of Revenue to Revenue		 35.66% 35.80% 33.61% 36.82% 36.51% 39.06% 35.99% 30.29% 33.27% 32.55% 33.55%
SG&A Expenses to Revenue		 30.03% 30.07% 36.28% 41.72% 50.55% 40.48% 37.35% 30.00% 34.40% 46.99% 26.89%
R&D to Revenue		 28.11% 28.61% 31.53% 28.78% 28.28% 27.87% 25.97% 21.33% 21.10% 19.09% 21.87%
Operating Expenses to Revenue		 86.19% 87.41% 97.87% 102.47% 106.33% 247.96% 90.84% 74.16% 79.39% -18.82% 82.24%
Earnings before Interest and Taxes (EBIT)		 -18 -20 -26 -28 -27 -121 -20 -4.20 -10 75 -13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -13 -16 -22 -24 -23 -118 -13 0.13 -4.96 79 -7.30
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.08 1.42 1.17 1.13 0.96 2.48 2.14 3.06 6.03 3.03 2.59
Price to Tangible Book Value (P/TBV)		 2.56 1.74 1.47 1.42 1.23 3.70 3.18 4.43 8.55 3.83 3.26
Price to Revenue (P/Rev)		 2.86 1.90 1.53 1.48 1.28 2.32 1.99 2.72 5.27 3.44 2.84
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 21.85 15.85
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 4.58% 6.31%
Enterprise Value to Invested Capital (EV/IC)		 4.26 2.31 1.53 1.43 0.89 16.34 8.09 15.75 42.46 7.57 5.09
Enterprise Value to Revenue (EV/Rev)		 1.94 0.99 0.64 0.56 0.37 1.48 1.21 1.95 4.50 2.66 2.17
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 14.44 10.70
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 21.60 14.80
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 21.90 15.18
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 627.94 0.00 0.00 0.00 0.00 180.76 23.33 28.12
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.72 -0.72 -0.69 -0.69 -0.67 -0.77 -0.74 -0.76 -0.76 -0.78 -0.70
Leverage Ratio		 1.22 1.24 1.22 1.24 1.26 1.46 1.45 1.47 1.47 1.50 1.48
Compound Leverage Factor		 1.14 1.12 1.10 1.12 1.11 1.42 1.24 0.48 1.03 1.56 1.17
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 5.10 3.24 2.56 2.21 1.70 0.21 0.61 1.54 4.00 6.16 4.80
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 5.52 5.11 5.17 4.84 4.75 4.02 4.32 4.09 4.10 3.94 4.11
Quick Ratio		 5.15 4.73 4.81 4.49 4.40 3.67 3.93 3.77 3.78 3.64 3.55
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -49 -34 -12 -4.17 -0.31 26 79 82 85 -17 -116
Operating Cash Flow to CapEx		 -146.08% 219.26% 24.22% -21.13% -629.50% -525.78% -1,029.72% 1,058.60% 743.15% 1,438.17% -1,630.92%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.58 0.58 0.59 0.59 0.57 0.56 0.56 0.61 0.64 0.70 0.74
Accounts Receivable Turnover		 5.03 5.10 5.13 5.08 4.87 4.78 4.61 5.04 5.29 5.77 5.26
Inventory Turnover		 5.95 6.16 6.14 5.82 5.87 5.27 5.35 5.46 5.75 5.63 5.21
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.70 10.32
Accounts Payable Turnover		 8.60 9.64 9.49 8.19 10.81 8.94 8.93 13.21 14.08 10.67 12.42
Days Sales Outstanding (DSO)		 72.52 71.50 71.16 71.85 75.00 76.41 79.25 72.36 69.04 63.24 69.35
Days Inventory Outstanding (DIO)		 61.35 59.23 59.41 62.75 62.16 69.25 68.28 66.80 63.48 64.88 70.09
Days Payable Outstanding (DPO)		 42.45 37.86 38.48 44.56 33.78 40.82 40.87 27.64 25.93 34.22 29.38
Cash Conversion Cycle (CCC)		 91.42 92.87 92.09 90.04 103.39 104.84 106.65 111.51 106.59 93.90 110.06
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 145 137 134 122 125 25 41 37 33 117 148
Invested Capital Turnover		 2.51 2.53 2.35 2.39 2.20 3.45 3.15 3.74 3.95 4.68 3.67
Increase / (Decrease) in Invested Capital		 37 20 -4.55 -15 -20 -112 -92 -85 -92 92 107
Enterprise Value (EV)		 619 318 205 175 111 414 332 580 1,406 888 753
Market Capitalization		 910 611 491 457 379 649 548 809 1,647 1,148 984
Book Value per Share		 $8.17 $8.05 $7.83 $7.53 $7.28 $4.83 $4.95 $5.08 $5.18 $7.06 $6.84
Tangible Book Value per Share		 $6.65 $6.54 $6.24 $5.99 $5.68 $3.24 $3.33 $3.50 $3.65 $5.59 $5.44
Total Capital		 437 431 420 405 394 261 256 265 273 378 379
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -291 -293 -286 -283 -268 -235 -216 -229 -241 -261 -231
Capital Expenditures (CapEx)		 4.85 3.28 2.77 2.36 1.62 1.59 1.49 1.79 1.69 1.52 1.63
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 27 19 14 3.65 4.31 0.22 17 13 12 1.81 34
Debt-free Net Working Capital (DFNWC)		 318 312 300 286 272 236 233 242 253 262 265
Net Working Capital (NWC)		 318 312 300 286 272 236 233 242 253 262 265
Net Nonoperating Expense (NNE)		 4.80 4.95 6.72 5.62 3.34 32 3.12 -1.47 0.06 -3.48 0.99
Net Nonoperating Obligations (NNO)		 -291 -294 -286 -283 -269 -236 -215 -228 -240 -261 -231
Total Depreciation and Amortization (D&A)		 4.78 3.90 3.99 3.66 3.71 3.53 6.67 4.33 5.25 4.13 5.78
Debt-free, Cash-free Net Working Capital to Revenue		 8.35% 5.84% 4.27% 1.18% 1.45% 0.08% 6.17% 4.51% 3.77% 0.54% 9.83%
Debt-free Net Working Capital to Revenue		 99.76% 96.92% 93.73% 92.57% 91.71% 84.06% 84.65% 81.55% 80.78% 78.63% 76.48%
Net Working Capital to Revenue		 99.76% 96.92% 93.73% 92.57% 91.71% 84.06% 84.65% 81.55% 80.78% 78.63% 76.48%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.32) ($0.34) ($0.44) ($0.46) ($0.43) ($2.21) ($0.32) ($0.03) ($0.14) $1.49 ($0.19)
Adjusted Weighted Average Basic Shares Outstanding		 53.49M 53.32M 53.64M 53.85M 54.18M 53.76M 51.69M 52.20M 52.90M 52.77M 55.26M
Adjusted Diluted Earnings per Share		 ($0.32) ($0.34) ($0.44) ($0.46) ($0.43) ($2.21) ($0.32) ($0.03) ($0.14) $1.42 ($0.19)
Adjusted Weighted Average Diluted Shares Outstanding		 53.49M 53.32M 53.64M 53.85M 54.18M 53.76M 51.69M 52.20M 52.90M 56.62M 55.26M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 53.54M 53.67M 53.79M 54.17M 54.10M 51.78M 52.08M 52.74M 53.63M 55.43M 55.68M
Normalized Net Operating Profit after Tax (NOPAT)		 -12 -13 -17 -19 -20 -86 -14 -2.82 -7.34 75 -5.61
Normalized NOPAT Margin		 -15.29% -16.25% -22.04% -26.66% -29.99% -130.92% -18.79% -3.06% -8.86% 86.08% -6.62%
Pre Tax Income Margin		 -21.01% -22.04% -30.58% -35.59% -35.07% -179.86% -23.24% -1.49% -8.70% 90.30% -12.16%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -0.84% -1.65% -1.67% -2.44% -14.47% -14.94% -17.11% -18.45% 0.99% 0.00%

Frequently Asked Questions About CareDx's Financials

When does CareDx's fiscal year end?

According to the most recent income statement we have on file, CareDx's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has CareDx's net income changed over the last 10 years?

CareDx's net income appears to be on an upward trend, with a most recent value of $52.55 million in 2024, rising from $781 thousand in 2014. The previous period was -$190.28 million in 2023. See CareDx's forecast for analyst expectations on what’s next for the company.

What is CareDx's operating income?
CareDx's total operating income in 2024 was $40.77 million, based on the following breakdown:
  • Total Gross Profit: $224.16 million
  • Total Operating Expenses: $183.39 million
How has CareDx revenue changed over the last 10 years?

Over the last 10 years, CareDx's total revenue changed from $27.31 million in 2014 to $333.79 million in 2024, a change of 1,122.4%.

How much debt does CareDx have?

CareDx's total liabilities were at $112.62 million at the end of 2024, a 45.2% decrease from 2023, and a 467.5% increase since 2014.

How much cash does CareDx have?

In the past 10 years, CareDx's cash and equivalents has ranged from $16.90 million in 2017 to $348.49 million in 2021, and is currently $114.69 million as of their latest financial filing in 2024.

How has CareDx's book value per share changed over the last 10 years?

Over the last 10 years, CareDx's book value per share changed from 3.50 in 2014 to 7.06 in 2024, a change of 101.7%.


Related Companies

This page (NASDAQ:CDNA) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...
Porter & Company | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...
Weiss Ratings | Sponsored
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...
Altimetry | Sponsored
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored
Will May start the next "Great Depression?"
You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...
Behind the Markets | Sponsored
Gold Alert: The Truth About Fort Knox Is Coming
Owning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...
Golden Portfolio | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
The July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...
Crypto Swap Profits | Sponsored
All Signs Point To Collapse - 401(k)s/IRAs /Are Doomed
Retiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road Ahead
American Hartford Gold | Sponsored